$72.99
0.15% today
NYSE, Feb 05, 04:22 pm CET
ISIN
US2074101013
Symbol
CNMD

Conmed Corp. Stock price

$72.88
+4.30 6.27% 1M
+7.25 11.05% 6M
+4.44 6.49% YTD
-9.60 11.64% 1Y
-66.15 47.58% 3Y
-30.25 29.33% 5Y
+24.87 51.80% 10Y
NYSE, Closing price Tue, Feb 04 2025
+1.67 2.35%
ISIN
US2074101013
Symbol
CNMD
Sector

Key metrics

Market capitalization $2.25b
Enterprise Value $3.15b
P/E (TTM) P/E ratio 17.28
EV/FCF (TTM) EV/FCF 18.98
EV/Sales (TTM) EV/Sales 2.45
P/S ratio (TTM) P/S ratio 1.75
P/B ratio (TTM) P/B ratio 2.41
Dividend yield 1.10%
Last dividend (FY24) $0.80
Revenue growth (TTM) Revenue growth 10.64%
Revenue (TTM) Revenue $1.28b
EBIT (operating result TTM) EBIT $159.68m
Free Cash Flow (TTM) Free Cash Flow $166.13m
Cash position $38.47m
EPS (TTM) EPS $4.22
P/E forward 18.12
P/S forward 1.73
EV/Sales forward 2.42
Short interest 10.46%
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

Buy
57%
Hold
43%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,285 1,285
11% 11%
100%
- Direct Costs 612 612
8% 8%
48%
673 673
14% 14%
52%
- Selling and Administrative Expenses 401 401
0% 0%
31%
- Research and Development Expense 55 55
9% 9%
4%
216 216
54% 54%
17%
- Depreciation and Amortization 56 56
0% 0%
4%
EBIT (Operating Income) EBIT 160 160
91% 91%
12%
Net Profit 132 132
127% 127%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
30 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and ...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 4:30 p.m. PT (7:30 p.m. ET) on Monday, January 13, 2025 in San Francisco, CA. A live audio webcast of the presentation will be...
Neutral
Business Wire
about 2 months ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Comp...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 4,000
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today